These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1378113)

  • 21. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans.
    Blitzer ML; Loh E; Roddy MA; Stamler JS; Creager MA
    J Am Coll Cardiol; 1996 Sep; 28(3):591-6. PubMed ID: 8772744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of hypertonic saline dextran solutions on hypoxic pulmonary vasoconstriction in anaesthetised piglets.
    Bellezza M; Kerbaul F; Roussel L; Imbert M; Guidon C
    Eur Respir J; 2002 Oct; 20(4):965-71. PubMed ID: 12412690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled nitric oxide partially reverses hypoxic pulmonary vasoconstriction in the dog.
    Romand JA; Pinsky MR; Firestone L; Zar HA; Lancaster JR
    J Appl Physiol (1985); 1994 Mar; 76(3):1350-5. PubMed ID: 8005882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dibutyryl cyclic AMP inhibits acute hypoxic pulmonary vasoconstriction in conscious sheep.
    Koyama S; Kobayashi T; Sakai A; Yoshimura K
    Am Rev Respir Dis; 1988 Apr; 137(4):779-82. PubMed ID: 2833140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.
    Wang M; Shibamoto T; Kuda Y; Tanida M; Kurata Y
    Exp Lung Res; 2015; 41(6):324-34. PubMed ID: 26151368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin produces pulmonary vasoconstriction and systemic vasodilation.
    Lippton HL; Hauth TA; Summer WR; Hyman AL
    J Appl Physiol (1985); 1989 Feb; 66(2):1008-12. PubMed ID: 2565328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological doses of atrial natriuretic factor do not inhibit canine hypoxic pulmonary vasoconstriction.
    Vachiery JL; Lejeune P; Brimioulle S; Debiève MF; Abramow M; Naeije R
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):842-5. PubMed ID: 2481770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can intravenous endothelin-1 be used to enhance hypoxic pulmonary vasoconstriction in healthy humans?
    Talbot NP; Balanos GM; Robbins PA; Dorrington KL
    Br J Anaesth; 2008 Oct; 101(4):466-72. PubMed ID: 18640991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of G proteins in the vasodilator response to endothelin isopeptides in vivo.
    Lippton HL; Hao Q; Erdemli O; Hyman A
    J Appl Physiol (1985); 1995 Jun; 78(6):2062-9. PubMed ID: 7665400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-3 is a potent pulmonary vasodilator in the rat.
    Crawley DE; Liu SF; Barnes PJ; Evans TW
    J Appl Physiol (1985); 1992 Apr; 72(4):1425-31. PubMed ID: 1592734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for distinct endothelin receptors in the pulmonary vascular bed in vivo.
    Lippton HL; Cohen GA; Knight M; McMurtry IF; Gillot D; Arena F; Summer W; Hyman AL
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S370-3. PubMed ID: 1725383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of endothelin in chronic hypoxic rats.
    Chen CF; Chien CT; Chiu IS
    Chin J Physiol; 1992; 35(2):95-104. PubMed ID: 1451576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange.
    Pison U; López FA; Heidelmeyer CF; Rossaint R; Falke KJ
    J Appl Physiol (1985); 1993 Mar; 74(3):1287-92. PubMed ID: 8482669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hypoxic pulmonary vasoconstriction by carbon monoxide in dogs.
    Vassalli F; Pierre S; Julien V; Bouckaert Y; Brimioulle S; Naeije R
    Crit Care Med; 2001 Feb; 29(2):359-66. PubMed ID: 11246317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium attenuates endothelin-1-induced vasoreactivity and enhances vasodilatation in mouse pulmonary arteries: Modulation by chronic hypoxic pulmonary hypertension.
    Mu YP; Huang QH; Zhu JL; Zheng SY; Yan FR; Zhuang XL; Sham JSK; Lin MJ
    Exp Physiol; 2018 Apr; 103(4):604-616. PubMed ID: 29363240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equine pulmonary and systemic haemodynamic responses to endothelin-1 and a selective ET(A) receptor antagonist.
    Benamou AE; Marlin DJ; Lekeux P
    Equine Vet J; 2001 Jul; 33(4):337-44. PubMed ID: 11469765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A blind, randomized comparison of the circulatory effects of dopamine and epinephrine infusions in the newborn piglet during normoxia and hypoxia.
    Barrington KJ; Finer NN; Chan WK
    Crit Care Med; 1995 Apr; 23(4):740-8. PubMed ID: 7712765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
    Hedelin P; Kylhammar D; Rådegran G
    Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction.
    Petersen B; Deja M; Bartholdy R; Donaubauer B; Laudi S; Francis RC; Boemke W; Kaisers U; Busch T
    Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R601-5. PubMed ID: 18077516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amrinone and the pulmonary vascular pressure-flow relationship in conscious control dogs and following left lung autotransplantation.
    Nyhan DP; Pribble CG; Peterson WP; Nishiwaki K; Trempy GA; Desai PM; Rock P; Murray PA
    Anesthesiology; 1993 Jun; 78(6):1166-74. PubMed ID: 8512111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.